Google has unveiled AlphaGenome 2, an advanced technology aimed at helping researchers and medical professionals identify the underlying causes of diseases. Announced in November 2026, the new system represents an ongoing effort by Google to apply computational tools and artificial intelligence to complex biological and medical challenges. While specific technical architecture and deployment details were not elaborated in the initial announcement, the tool is intended to streamline the process of understanding disease origins, potentially aiding future diagnostics and biomedical research.